Trump Tariff: Analyzing India’s Medical Device Regulations and Their Impact on US Exports
Trump Tariff: Analyzing India’s Medical Device Regulations
The Trump tariff measures have significant implications for India’s medical device sector, contributing to a growing trade imbalance between the US and India. According to a fact sheet released by the White House, stringent regulations within India are impeding the ability of US companies to export their products to India. Specifically, the fact sheet indicates that if testing and certification barriers were eliminated, US exports could increase by more than $5.3 billion annually.
Understanding the Trade Imbalance
- The US imposes a 2.5% tariff on passenger vehicle imports, whereas India imposes a hefty 70% tariff.
- Networking switches and routers are subject to 0% tariffs in the US compared to India’s 10-20% tariffs.
- For rice in the husk, the US has a 2.7% tariff, while India’s rate soars to 80%.
- Apples are imported duty-free into the US, but face a 50% tariff in India.
With these circumstances, Trump tariffs come into effect, and starting today, Indian goods will face a 25% tariff on steel, aluminum, and automobiles. A baseline tariff of 10% will apply to other products, increasing to a specific 27% rate by April 9.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.